These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
588 related articles for article (PubMed ID: 9579642)
41. Inhibition of platelet aggregation after intake of acetylsalicylic acid detected by a platelet function analyzer (PFA-100). Feuring M; Haseroth K; Janson CP; Falkenstein E; Schmidt BM; Wehling M Int J Clin Pharmacol Ther; 1999 Dec; 37(12):584-8. PubMed ID: 10599950 [TBL] [Abstract][Full Text] [Related]
42. Clinical utility of the PFA-100. Favaloro EJ Semin Thromb Hemost; 2008 Nov; 34(8):709-33. PubMed ID: 19214910 [TBL] [Abstract][Full Text] [Related]
43. Evaluation of the INNOVANCE PFA P2Y test cartridge: sensitivity to P2Y(12) blockade and influence of anticoagulant. Edwards A; Jakubowski JA; Rechner AR; Sugidachi A; Harrison P Platelets; 2012; 23(2):106-15. PubMed ID: 21848368 [TBL] [Abstract][Full Text] [Related]
44. Variables that affect platelet function analyzer-100 (PFA-100) closure times and establishment of reference intervals in Korean adults. Cho YU; Jang S; Park CJ; Chi HS Ann Clin Lab Sci; 2008; 38(3):247-53. PubMed ID: 18715853 [TBL] [Abstract][Full Text] [Related]
45. Effect of aspirin treatment in patients with peripheral arterial disease monitored with the platelet function analyzer PFA-100. Roller RE; Dorr A; Ulrich S; Pilger E Blood Coagul Fibrinolysis; 2002 Jun; 13(4):277-81. PubMed ID: 12032391 [TBL] [Abstract][Full Text] [Related]
46. Evaluation of a Platelet Function Analyser (PFA-100) in patients with a bleeding tendency. Wuillemin WA; Gasser Ka; Zeerleder SS; Lämmle B Swiss Med Wkly; 2002 Aug; 132(31-32):443-8. PubMed ID: 12457302 [TBL] [Abstract][Full Text] [Related]
47. Factors responsible for "aspirin resistance" - can we identify them? Postuła M; Tarchalska-Kryńska B; Filipiak KJ; Kosior D; Serafin A; Huczek Z; Opolski G Kardiol Pol; 2010 Apr; 68(4):403-11; discussion 412-3. PubMed ID: 20425699 [TBL] [Abstract][Full Text] [Related]
48. Platelet function testing to assess effectiveness of platelet transfusion therapy. Salama ME; Raman S; Drew MJ; Abdel-Raheem M; Mahmood MN Transfus Apher Sci; 2004 Apr; 30(2):93-100. PubMed ID: 15062745 [TBL] [Abstract][Full Text] [Related]
49. Assessment of platelet function on whole blood by multiple electrode aggregometry in high-risk patients with coronary artery disease receiving antiplatelet therapy. Paniccia R; Antonucci E; Maggini N; Romano E; Gori AM; Marcucci R; Prisco D; Abbate R Am J Clin Pathol; 2009 Jun; 131(6):834-42. PubMed ID: 19461090 [TBL] [Abstract][Full Text] [Related]
50. Cross validation of aspirin effect in healthy individuals by Impact-R and PFA-100: a double blind randomized placebo controlled trial. Gouya G; Jilma B; Niel M; Eichelberger B; Wolzt M; Panzer S Platelets; 2009 May; 20(3):171-6. PubMed ID: 19437334 [TBL] [Abstract][Full Text] [Related]
51. Duration of effects of aspirin on platelet function in healthy volunteers: an analysis using the PFA-100. Konrad CJ; Schuepfer GK; Gerber H; Rukwied R; Schmelz M; Schley M J Clin Anesth; 2006 Feb; 18(1):12-7. PubMed ID: 16517326 [TBL] [Abstract][Full Text] [Related]
52. Comparison of PFA-100 closure time and template bleeding time of patients with inherited disorders causing defective platelet function. Kerényi A; Schlammadinger A; Ajzner E; Szegedi I; Kiss C; Pap Z; Boda Z; Muszbek L Thromb Res; 1999 Dec; 96(6):487-92. PubMed ID: 10632473 [No Abstract] [Full Text] [Related]
53. [Acetylsalicylic acid (ASA) resistance in patients with ischemic heart disease (IHD) as bioindicator of the treatment strategy]. Malý J; Pecka M; Gregor J; Dulícek P; Blazek M; Malý R; Pudil R; Bláha M Cas Lek Cesk; 2005; 144 Suppl 3():23-9. PubMed ID: 16335259 [TBL] [Abstract][Full Text] [Related]
54. The role of PFA-100 testing in the investigation and management of haemostatic defects in children and adults. Harrison P Br J Haematol; 2005 Jul; 130(1):3-10. PubMed ID: 15982339 [TBL] [Abstract][Full Text] [Related]
55. Persistent platelet activation is related to very early cardiovascular events in patients with acute coronary syndromes. Małek ŁA; Spiewak M; Filipiak KJ; Grabowski M; Szpotańska M; Rosiak M; Główczyńska R; Imiela T; Huczek Z; Opolski G Kardiol Pol; 2007 Jan; 65(1):40-5; discussion 46. PubMed ID: 17295159 [TBL] [Abstract][Full Text] [Related]
56. Impaired platelet function among platelet donors. Jilma-Stohlawetz P; Hergovich N; Homoncik M; Dzirlo L; Horvath M; Janisiw M; Panzer S; Jilma B Thromb Haemost; 2001 Sep; 86(3):880-6. PubMed ID: 11583322 [TBL] [Abstract][Full Text] [Related]
57. External quality assessment/proficiency testing and internal quality control for the PFA-100 and PFA-200: an update. Favaloro EJ; Bonar R Semin Thromb Hemost; 2014 Mar; 40(2):239-53. PubMed ID: 24497116 [TBL] [Abstract][Full Text] [Related]
58. Evaluation of the PFA-100 system in the diagnosis and therapeutic monitoring of patients with von Willebrand disease. Cattaneo M; Federici AB; Lecchi A; Agati B; Lombardi R; Stabile F; Bucciarelli P Thromb Haemost; 1999 Jul; 82(1):35-9. PubMed ID: 10456451 [TBL] [Abstract][Full Text] [Related]
59. The impact of intravenous aspirin administration on platelet aspirin resistance after on-pump coronary artery bypass surgery. Bach J; Kammerer I; Isgro F; Haubelt H; Vogt A; Saggau W; Hellstern P Platelets; 2009 May; 20(3):150-7. PubMed ID: 19437331 [TBL] [Abstract][Full Text] [Related]
60. Utility of the PFA-100 as a screening test of platelet function: an audit of haemostasis laboratories in Australia and New Zealand. Favaloro EJ; Bonar R; Duncan E; Rodgers S; Marsden K; Blood Coagul Fibrinolysis; 2007 Jul; 18(5):441-8. PubMed ID: 17581318 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]